Biohaven's (BHVN) "Buy" Rating Reiterated at HC Wainwright

Biohaven's (BHVN) "Buy" Rating Reiterated At HC Wainwright

1 week from now

3 days ago  · Biohaven (NYSE:BHVN - Get Free Report) 's stock had its "buy" rating restated by HC Wainwright in a note issued to investors on Thursday, Benzinga reports. They presently have a $59.00 price objective on the stock. HC Wainwright's price target would suggest a potential upside of 20.21% from the company's previous close. Get Biohaven alerts:

marketbeat.com

Biohaven Ltd. (BHVN) Analyst Ratings - Stock Analysis

1 week from now

A list of analyst ratings for Biohaven (BHVN) stock. See upgrades, downgrades, price targets and more from top Wall Street stock analysts. ... HC Wainwright & Co. HC Wainwright & Co. Strong Buy. Reiterates. $59. Strong Buy: Reiterates: $59 +42.89%: May 30, 2024 : Charles Duncan. Cantor Fitzgerald. Cantor Fitzgerald : Buy.

stockanalysis.com

Buy Rating Affirmed For Biohaven On Promising Troriluzole SCA …

1 week from now

Sep 24, 2024  · J.P. Morgan analyst Tessa Romero has maintained their bullish stance on BHVN stock, giving a Buy rating today. ... H.C. Wainwright also reiterated a Buy rating on the stock with a $59.00 price target.

businessinsider.com

BHVN News Today | Why Did Biohaven Stock Go Down Today?

1 week from now

2 days ago  · Biohaven's (BHVN) "Buy" Rating Reiterated at HC Wainwright. HC Wainwright restated a "buy" rating and issued a $59.00 target price on shares of Biohaven in a research note on Thursday. November 14 at 8:31 AM | marketbeat.com. Royal Bank of Canada Lowers Biohaven (NYSE:BHVN) Price Target to $66.00 ...

marketbeat.com

Buy Rating Affirmed: Biohaven’s Innovative Pipeline And Financial ...

1 week from now

Mar 5, 2024  · Analyst Brian Skorney of Robert W. Baird maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report), ... H.C. Wainwright also maintained a Buy rating on the stock with a $63.00 price target.

businessinsider.com

HC Wainwright & Co. Initiates Coverage Of Biohaven (BHVN) With …

1 week from now

Dec 18, 2023  · Fintel reports that on December 22, 2023, HC Wainwright & Co. initiated coverage of Biohaven with a Buy recommendation. Analyst Price Forecast Suggests 5.47% Downside. As of December 18, 2023, the ...

nasdaq.com

HC Wainwright & Co. Reiterates Buy On Biohaven, Maintains $59 …

1 week from now

HC Wainwright & Co. analyst Douglas Tsao reiterates Biohaven (NYSE:BHVN) with a Buy and maintains $59 price target. ... HC Wainwright & Co. analyst Douglas Tsao reiterates Biohaven (NYSE:BHVN) with a Buy and maintains $59 price target. ... Rating Analyst; 7/24/2024: $58.00: Overweight: Morgan Stanley. 2/16/2024: $62.00: Outperform: RBC Capital ...

quantisnow.com

Biohaven Ltd. (NYSE:BHVN) Receives $54.70 Average PT From …

1 week from now

Sep 18, 2024  · Finally, HC Wainwright reiterated a "buy" rating and set a $59.00 target price on shares of Biohaven in a research report on Thursday, May 30th. Read Our Latest Report on BHVN. Biohaven Price Performance. Shares of NYSE:BHVN traded up $0.40 during trading on Wednesday, reaching $39.40. The company had a trading volume of 1,100,294 shares ...

marketbeat.com

H.C. Wainwright Reiterates Buy Rating On Biohaven Pharmaceutical ...

1 week from now

Sep 24, 2024  · H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $59.00 price target on Biohaven Pharmaceutical Holding (NYSE: BHVN).The analyst commented: "In what came across as an unexpected...

streetinsider.com

Biohaven's (BHVN) "Overweight" Rating Reiterated At Cantor …

1 week from now

Oct 23, 2024  · BHVN has been the subject of several other reports. Piper Sandler upped their target price on Biohaven from $66.00 to $76.00 and gave the company an "overweight" rating in a report on Monday, September 23rd. Sanford C. Bernstein upped their price target on Biohaven from $55.00 to $66.00 and gave the company an "outperform" rating in a research ...

marketbeat.com

Biohaven’s (BHVN) Overweight Rating Reiterated At Cantor …

1 week from now

Oct 26, 2024  · Cantor Fitzgerald reiterated their overweight rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report issued on Wednesday, Benzinga reports. Other equities analysts have also issued research reports about the stock. Robert W. Baird boosted their price target on shares of Biohaven from $58.00 to $60.00 and gave the company an “outperform” …

americanbankingnews.com

Buy Rating Affirmed For Biohaven Ltd. Amid Positive Clinical …

1 week from now

Apr 14, 2024  · Biohaven price target raised to $63 from $50 at H.C. Wainwright Biohaven price target raised to $55 from $35 at TD Cowen Biohaven reports Q4 non-GAAP EPS ($1.61), consensus ($1.41)

businessinsider.com

BofA Securities Reiterates Buy Rating On Biohaven Pharmaceutical ...

1 week from now

Oct 15, 2024  · BofA Securities analyst Jason Gerberry reiterated a Buy rating and $65.00 price target on Biohaven Pharmaceutical Holding (NYSE: BHVN).The analyst comments "Our recent neurology expert checks ...

streetinsider.com

Biohaven (BHVN) Stock Forecast And Price Target 2024 - MarketBeat

1 week from now

4 days ago  · HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating : Reiterated Rating: Buy Buy: $59.00 $59.00 +28.46%: 9/23/2024: Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating : Boost Target: Outperform Outperform: $55.00 $60.00 +30.63%: 9/23/2024

marketbeat.com

Analysts Offer Insights On Healthcare Companies: Biohaven Ltd.

1 week from now

Oct 9, 2024  · In a report issued on September 27, H.C. Wainwright also maintained a Buy rating on the stock with a $18.00 price target. Read More on BHVN: Biohaven price target raised to $65 from $63 at BofA

businessinsider.com

TD Cowen Reiterates Buy Rating On Biohaven Pharmaceutical …

1 week from now

Oct 1, 2024  · TD Cowen analyst Tyler Van Buren reiterated a Buy rating and $55.00 price target on Biohaven Pharmaceutical Holding (NYSE: BHVN).The analyst commented, "In SCA, Biohaven meticulously followed the...

streetinsider.com

Biohaven (BHVN) Stock Price, News & Analysis - MarketBeat

1 week from now

3 days ago  · Biohaven (BHVN) raised $124 million in an initial public offering (IPO) on Thursday, May 4th 2017. The company issued 8,300,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley, Piper Jaffray and Barclays Capital served as the underwriters for the IPO and William Blair and Needham & Company were co-managers.

marketbeat.com

Buy Rating Affirmed For Biohaven Ltd. On Promising Troriluzole …

1 week from now

Sep 24, 2024  · Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Biohaven Ltd. (BHVN – Research Report) yesterday and set a price target of $62.00.. Jason Gerberry has given his Buy ...

businessinsider.com